Source: VillageReach |

VillageReach Commences Program to Strengthen Epidemic Preparedness and Response Across Africa

The program addresses critical barriers to diagnosing infectious diseases such as polio, measles, yellow fever, Ebola, mpox and cholera by improving sample transport systems

VillageReach (www.VillageReach.org) announces the launch of a program funded by Takeda Pharmaceutical Company Limited to enhance laboratory sample referral and transportation systems for epidemic-prone infectious diseases across Africa. This initiative, which commenced in January 2025, will strengthen health systems in the Democratic Republic of Congo (DRC), Guinea, Malawi, Tanzania and…

Vestergaard Sàrl
  • Multimedia content

  • Images (3)
    • Tiny Targets are small screens of insecticidal fabric that are placed along local riverbanks and close to water sources to successfully attract and kill the tsetse flies that transmit sleeping sickness. Photo courtesy of Sophie Dunkley (1)
    • Tiny Targets are small screens of insecticidal fabric that are placed along local riverbanks and close to water sources to successfully attract and kill the tsetse flies that transmit sleeping sickness. Photo courtesy of Sophie Dunkley (2)
    • CEO Amar Ali and CFOO Nicolas Schornoz sign the Kigali Declaration
  • All (3)
Source: Vestergaard Sàrl |

Vestergaard formalizes Tiny Targets commitment to support sleeping sickness elimination, signs Kigali Declaration on World Neglected Tropical Disease (NTD) Day

The gambiense form of the disease accounts for 92% of all cases, and the majority of people exposed to the disease live in rural areas

Vestergaard Sàrl (www.Vestergaard.com) announced today, World Neglected Tropical Disease (NTD) Day, that it has signed the Kigali Declaration on NTDs (http://apo-opa.co/4gfeq9G), formalizing the company’s commitment to support sleeping sickness elimination efforts through the ongoing donation of “Tiny Targets” for vector control of the disease. The Kigali Declaration, launched in Kigali,…

FIND
  • Multimedia content

  • Images (1)
    • Dr Ifedayo Adetifa, Chief Transformation Officer and CEO of FIND
  • All (1)
Source: FIND |

Defeating Cervical Cancer: Improving Access to Testing to Save Lives

Cervical cancer is a preventable tragedy, and South Africa has the tools and knowledge to turn the tide

Although cervical cancer is now a vaccine-preventable disease, 1 woman dies every 2 minutes globally of cervical cancer. Women in low- and middle-income countries are disproportionately affected.  In South Africa (SA), over 10,700 new cases of cervical cancer are diagnosed each year, with over 5,800 deaths. Cervical cancer is a…

Source: World Health Organization - Regional Office for the Eastern Mediterranean |

How World Health Organization (WHO) is supporting cholera outbreak response in Sudan

The Federal Ministry of Health, with support from WHO and UNICEF, has conducted oral cholera vaccination campaigns in 8 states, reaching 7.4 million people

The Federal Ministry of Health of Sudan declared a cholera outbreak on 12 August 2024 after confirmation of samples from Kassala State, which has been reporting suspected cases since 22 July 2024. Fuelled by heavy rains and flooding, overcrowding and lack of access to clean water in displacement sites and…

Source: World Health Organization (WHO) |

World Health Organization (WHO) prequalifies diagnostic test to support safer administration of P. vivax malaria treatments

Decision reflects updated processes to improve efficiency, access

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection. The prequalification of this G6PD diagnostic test marks a significant milestone in facilitating safe and effective P.…

African Development Bank Group (AfDB)
  • Multimedia content

  • Images (1)
    • Visiting the IPD in January 2024, the President of the African Development Bank Group, Akinwumi Adesina ((1st right), announced its support for this important biomedical research centre in Africa
  • All (1)
Source: African Development Bank Group (AfDB) |

Global Partners Invest $45 Million to Boost African Vaccine Production

This collaboration will focus on expanding IPD’s state-of-the-art MADIBA facility, a hub for vaccine manufacturing, while driving job creation and economic growth

In significant efforts to strengthen public health and improve vaccine access in Africa, the U.S. International Development Finance Corporation, the African Development Bank (www.AfDB.org), and the International Finance Corporation (IFC) have jointly announced a $45 million financing package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). The…

EVA Pharma
  • Multimedia content

  • Images (1)
    • Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
  • All (1)
Source: EVA Pharma |

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

This milestone stems from the companies’ collaboration to expand access to affordable insulin to one million people living with diabetes in low-to middle-income countries annually by 2030

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma (www.EVAPharma.com) through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with…

Source: BRICS Competition Law and Policy Centre |

BRICS countries will create a barrier-free regulatory regime for biosimilars

Experts of the BRICS Working Group on Competition in Pharmaceutical Markets call for the removal of barriers to the regulation of the turnover of biological drugs and biosimilars in the BRICS+ countries

The HSE University BRICS Competition Law and Policy Centre (www.BRICSCompetition.org) has summarised the first results of its annual analytical study on bringing biotechnological drugs to the BRICS market. One of the conclusions of the report was the need to conduct a large-scale sectoral study on the removal of barriers in…

Source: World Health Organization (WHO) - Ethiopia |

World Health Organization (WHO) Receives Certificate of Merit for Contributions to Ethiopia's Pharmaceutical Sector

Established in 1974, the Ethiopian Pharmaceutical Association is a national body representing pharmacists in Ethiopia

The World Health Organization (WHO) has been awarded a Certificate of Merit by the Ethiopian Pharmaceutical Association (EPA) in recognition of its outstanding contributions to the pharmaceutical sector. The award was presented during EPA's celebration of its 50-year journey. WHO was honored for its extensive efforts in strengthening Ethiopia’s regulatory…

Informa Markets: Healthcare
  • Multimedia content

  • Images (3)
    • International Health Ministerial Summit (1)
    • International Health Ministerial Summit (2)
    • International Health Ministerial Summit (3)
  • All (3)
Source: Informa Markets: Healthcare |

Health equity and women’s health emerge as key themes of the inaugural International Health Ministerial Summit

The exclusive by-invitation only Summit, themed Strengthening Health Systems for a Better Tomorrow, takes place from 4 to 5 December 2024 at the Marriott in Kigali

The inaugural International Health Ministerial Summit, organised by Informa Markets (www.InformaMarkets.com), began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative solutions to global healthcare challenges. Hosting governmental figures and policymakers, corporate CEOs and investors, medical directors, and experts, the exclusive by-invitation only Summit, themed Strengthening Health…